Neuronetics Anti-Depression Device Not Equivalent To Shock Therapy – Panel
This article was originally published in The Gray Sheet
Executive Summary
Neuronetics' NeuroStar transcranial magnetic stimulation system is not substantially equivalent to electroconvulsive "shock" therapy for treatment of major depressive disorder, FDA's Neurological Devices Panel concluded Jan. 26